The United Arab Emirates Ministry of Health & Prevention has approved pricing for Iluvien, Alimera Sciences announced.
The pricing for the sustained-release fluocinolone acetonide intravitreal implant becomes effective Jan. 24, 2019. MEAgate International is the distributor of Iluvien in the UAE.
“The Middle East market has many patients living with diabetes and facing potential vision loss from diabetic macular edema,” Alimera CEO Dan Myers said in a press release. “With an approved price, Iluvien is now available in the UAE, enabling doctors to begin providing patients consistent treatment that controls the recurrence of edema every day.”